Please use this identifier to cite or link to this item:
Title: Early versus delayed percutaneous coronary intervention in patients with non-ST elevation acute coronary syndromes.
Austin Authors: Yudi, Matias B ;Ajani, Andrew E;Andrianopoulos, Nick;Duffy, Stephen J;Farouque, Omar ;Ramchand, Jay ;Gurvitch, Ronen;Lefkovits, Jeffrey;Freeman, Melanie;Brennan, Angela;Clark, David J ;Reid, Christopher;Eccleston, David
Affiliation: Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia
Department of Cardiology, Box Hill Hospital
Department of Cardiology, Austin Health, Heidelberg, Victoria, Australia
Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia
Department of Epidemiology & Preventive Medicine, Centre of Cardiovascular Research and Education in Therapeutics (CCRE), Monash University, Melbourne, Victoria, Australia
Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia
Issue Date: Aug-2016
Publication information: Coronary artery disease 2016; 27(5): 344-9
Abstract: The optimal timing of angiography and percutaneous coronary intervention (PCI) in patients with non-ST elevation acute coronary syndromes (NSTEACS) remains uncertain. We sought to assess clinical characteristics and outcomes of patients in real-world contemporary practice who have early versus delayed PCI for NSTEACS. We analyzed baseline clinical and procedural characteristics of 4307 patients with NSTEACS who underwent PCI from the Melbourne Interventional Group registry. Patients were assigned to the early PCI group if intervention was performed within a calendar day of presentation. The delayed PCI group received an intervention after one calendar day, but within the index admission. We assessed 30 days and 12-month mortality, myocardial infarction, target vessel revascularization, and major adverse cardiovascular events. The safety endpoint was in-hospital bleeding. Of the 4307 patients, 2210 (51%) received early PCI. The delayed PCI group were older (67±12 vs. 64±12, P<0.01), more likely to have biomarker elevation (70 vs. 66%, P<0.01), and had more comorbidities. There was no difference in efficacy at 30 days between the groups. At 12 months, delayed PCI was associated with higher mortality (4.6 vs. 3.3%, P=0.02), myocardial infarction (7.9 vs. 5.2%, P<0.01), and MACE (15.5 vs. 12.4%, P<0.01). On multivariate analysis, delayed PCI was not associated with increased mortality at 12 months (odds ratio 0.95, 95% confidence interval 0.7-1.3). In patients with stable NSTEACS treated with PCI, delayed intervention was performed in those who were older and had higher risk features. However, there appears to be no mortality hazard for these high-risk patients where PCI is delayed beyond the first 24 h after presentation and performed within the index admission.
DOI: 10.1097/MCA.0000000000000374
ORCID: 0000-0002-3706-4150
PubMed URL: 27097120
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Nov 28, 2022

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.